InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
5,459.10
(
1.11%
)
US TECH 100
18,514.00
(
1.00%
)
Dow Jones
40,589.34
(
1.64%
)
Brent Oil
79.75
(
0.00%
)
Bitcoin
68,920.72
(
1.48%
)
Post# of 89565
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

lowroller

Send PM Follow Ignore
Followers 5
Posts 941
Boards Moderated 0
Alias Born 08/28/2000

lowroller

Member Level

Re: None

Friday, 10/04/2002 9:11:33 AM

Friday, October 04, 2002 9:11:33 AM

Post# of 89565
Another longer term hold - IPXL
Schering-Plough announced today that Claritin OTC will take away from their prescription business. Here's where it's going:
June 24, 2002 -- IMPAX Laboratories, Inc. (Nasdaq NM: IPXL) today announced the signing of a Licensing, Contract Manufacturing and Supply Agreement with Schering-Plough Corporation relating to CLARITIN-D® 12 Hour (loratadine/pseudoephedrine sulfate, 5 mg/ 120 mg) Extended Release Tablets for the over-the-counter (OTC) market. CLARITIN-D 12 Hour is currently manufactured and marketed in the United States by Schering-Plough as a prescription drug for the relief of symptoms of seasonal allergic rhinitis (hay fever).

"Having no way as way -
Having no limitation as limitation"

"Using no way as way -
Having no limitation as limitation"

Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next
Join InvestorsHub

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up